Home
Management and Board
Product Pipeline
News
Contact Us
NEWS
Life Science Pharmaceuticals acquires three clinical stage monoclonal antibody programs from the Ludwig Institute for Cancer Research
Kyowa Hakko Kogyo Co. Ltd. grants Life Science Pharmaceuticals, Inc., a world-wide license to develop and market monoclonal antibody targeting melanoma
Life Science Pharmaceuticals Enters Into Agreement with Abbott to Develop Antibody 806
© 2010 Life Science Pharmaceuticals. All Rights Reserved
Terms of Use
Website design & development by Starting Line Design - For more information click
here
